发明名称 NEW 3'-4' CROSSLINKED NUCLEOSIDE AND OLIGONUCLEOTIDE ANALOGUE
摘要 <p>PROBLEM TO BE SOLVED: To obtain a new 3'-4' crosslinked nucleoside useful as an intermediate for producing an oligonucleotide analogue used as an antiviral drug, an anti- sense or anti-gene drug, or the like, which are stable and excellent. SOLUTION: This new compound is represented by formula I (R1 and R2 are each H, phosphate group; A is a 1-4C alkylene; B is purin-9-yl, or the like) and is preferably 3'-O,4'-C-ethylene-5-methyluridine. The compound of formula I is obtained by reacting a compound of formula II (X and Y are each a protecting group) with an eliminable group-introducing reagent such as p- toluenesulfonylchloride, an acid anhydride such as acetic anhydride and a trimethylsilylation product corresponding to a purine or pyrimidine capable of containing a desired substituent in order, and then eliminating a protecting group Y of a produced compound of formula III (R9 is a group for forming an eliminable group together in association with oxygen; Z is an acryl; B1 is purin-9-yl, or the like) and simultaneously performing cyclization reaction of a deprotected 3'OH and a group of OR9.</p>
申请公布号 JP2001064296(A) 申请公布日期 2001.03.13
申请号 JP20000187448 申请日期 2000.06.22
申请人 SANKYO CO LTD 发明人 KANEKO MASAKATSU;MORITA KOJI;IMANISHI TAKESHI
分类号 C07H19/06;A61K31/7042;A61K31/7052;A61K31/7064;A61K31/7068;A61K31/7072;A61K31/7076;A61K31/708;A61K31/712;A61K48/00;A61P31/12;C07H19/16;C07H21/00;(IPC1-7):C07H19/06 主分类号 C07H19/06
代理机构 代理人
主权项
地址